GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Patient Information Leaflet last updated on the eMC: 22/08/2011
PIL Havrix Monodose Vaccine

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 22/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 24/08/2009 and displayed until 22/08/2011
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to date of revision
Updated on 09/12/2008 and displayed until 24/08/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 11/04/2006 and displayed until 09/12/2008
Reasons for adding or updating:
  • Change to how to administer the medicine
  • Change to how the medicine works
Updated on 16/11/2004 and displayed until 11/04/2006
Reasons for adding or updating:
  • Company name change or merger
Updated on 10/05/2002 and displayed until 16/11/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 09/04/2001 and displayed until 10/05/2002
Reasons for adding or updating:
  • No reasons supplied
Updated on 10/08/2000 and displayed until 09/04/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   hepatitis a vaccine